Santen transfers Advanced Vision Science to SpyGlass Pharma

Bitget2026/10/01 23:32

By:Bitget

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SpyGlass Pharma agreed to acquire Advanced Vision Science, a wholly owned Santen unit, via purchase of all outstanding shares.
Advanced Vision Science develops, manufactures, sells ophthalmic devices, including intraocular lenses and lens materials.
The deal supports Santen’s portfolio optimization, while expanding SpyGlass’s manufacturing capacity for its ophthalmic pipeline.
Santen will keep its intraocular lens business in Japan, with Advanced Vision Science remaining an exclusive supplier for several lens types.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Santen Pharmaceutical Co. Ltd. published the original content used to generate this news brief on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Santen transfers Advanced Vision Science to SpyGlass Pharma

You may also like

Crypto prices